To explore the potential of NAF-1 to affect Fe ion and ROS metabolism in cancer cells (Tamir et al., 2015), we examined the level of expression of transferrin receptors and the site of ROS accumulation in breast cancer cells with suppressed NAF-1 expression. Here, NAF1 is linked to breast carcinoma.